According to WHO, approximately 80 percent of people in developing countries still rely on traditional medicine, which is based primarily on plant and animal species, for primary health care. Because of the toxicity and side effects of allopathic drugs, herbal therapy is becoming more popular. Medicinal plants are crucial in the development of powerful therapeutic agents. Natural products derived from plants, animals, and minerals have long been used to treat human disease Plant medicines are frequently used in combination rather than alone to maximise the benefit of their combined strength. Because of synergism, polyherbalism provides a variety of benefits not found in single herbal formulations. Polymers are the building blocks of a pharmaceutical drug delivery system because they control drug release from the device. Polymers are used to protect drugs from the physiological environment and to extend their release time in order to improve their stability. This review focuses on matrix tablets, which are one of the most practical methods for developing sustained-release dosage forms, as well as the approaches used in their formulation and evaluation. The therapeutic efficacy of a sustained release matrix tablet with improved efficacy can be increased. It also emphasizes the significance of polyherbalism and matrix Tablet.
Cite this article:
eha Quadri, Md. Semimul Akhtar. Novel Approaches of Polyherbal Matrix Tablet and its Evaluation Parameters. Research Journal of Pharmacy and Technology 2022; 15(12):5793-9. doi: 10.52711/0974-360X.2022.00978
eha Quadri, Md. Semimul Akhtar. Novel Approaches of Polyherbal Matrix Tablet and its Evaluation Parameters. Research Journal of Pharmacy and Technology 2022; 15(12):5793-9. doi: 10.52711/0974-360X.2022.00978 Available on: https://rjptonline.org/AbstractView.aspx?PID=2022-15-12-72
1. Maurya, H., and Kumar, T. Formulation, Standardization, and Evaluation of Polyherbal Dispersible Tablet. International Journal of Applied Pharmaceutics, 2019; 11:1-158. Doi:10.22159/Ijap.2019v11i1.30113.
2. Parasuraman, S., Thing, G., and Dhanaraj, S. Polyherbal formulation: Concept of ayurveda. Pharmacognosy Reviews, 2014; 8:16- 73. doi:10.4103/0973-7847.134229.
3. Swati Sharma, Polyherbal Formulation Development and Assessment of its Potential against Urolithiasis (Mutrakricchra) by In-Vitro Technique. Research Journal of Pharmacy and Technology.,2021; 14(4):1982-8. doi: 10.52711/0974-360X.2021.00351
4. Chandanpreet Singh Sidhu Pharmacognostical and Physico-chemical Evaluation of Ativishadi Churna – An Ayurvedic Formulation. Research Journal of Pharmacy and Technology. 2021; 14:3015-4. doi: 10.52711/0974-360X.2021.00528
5. Rohit Kumar, Wound Healing Potential of Polyherbal Formulation in Rats. Research Journal of Pharmacy and Technology. 2021; 144: 5-9. doi: 10.52711/0974-360X.2021.00389
6. Srivastava S, Lal and VK, Pant KK. Polyherbal formulations based on Indian medicinal plants asantidiabetic phytotherapeutics. Phytopharmacology, 2013; 2:1-15.
7. Baghel D. S., Chopra S., Bhatia A., Tamilvanan S. Amalgamation of Ayurvedic Concept with Modern Medical Practice to Manage Kidney Stone Disease (Urolithiasis): An Abbreviated Review. Indian Drugs, 2018; 11: 7-18.
8. M.N., Doddamani S.H., Giri S.K., Triveni D.P., Sulochana Bhat. Ayurvedic Management of Paediatric Urolithiasis (Mutrashmari): A Case Report. International Journal of Research in Ayurveda and Pharmacy, 2017; 55: 3-5
9. Mathew L, Babu S. Phytotherapy in India: Transition of tradition to technology. Curr Bot ,2011; 2:17-22.
10. Kumar S, Kant S and Prashar B. Sustained release drug delivery system. a review. International Journal of Institutional Pharmacy and Life Sciences, 2012; 2:356-376.
11. Pundir S, Badola A and Sharma D. Sustained release matrix technology and recent advance in matrix drug delivery system: a review.International Journal of Drug Research and Technology, 2013; 3:12-20.
12. Jaimini M and Kothari A. Sustained release matrix type drug delivery system: A review. Journal of Drug Delivery and Therapeutics,2012; 2:142-148.
13. Rathore AS, Jat RC, Sharma N, Tiwari R. An Overview: Matrix tablet as controlled drug delivery system. Int J Res Dev Pharm Life Sci, 2013; 2:482-492.
14. Remington R. The Science and Practice of Pharmacy. 21st ed. Wolter Kluwer Health, 2011; 90:939 -964.
15. Chugh I, Seth N, Rana AC, Gupta S. Oral sustains release drug delivery system: An overview. International Research Journal of Pharmacy2012; 3:57-62.
16. Pundir S, Badola A, Sharma D. Sustained release matrix technology and recent advance in matrix drug delivery system: A review. Int J Drug Res Tech Int J Drug Res Technol, 2013; 3:12-20.
17. Brahmankar DM, Jaiswal SB. Biopharmaceutics and Pharmacokinetics: Pharmacokinetics. 2nd ed. Delhi: Vallabh Prakashan,2009; 77:399-401.
18. Kulkarn Maushumi. Effect of Hydrophilic and Hydrophobic Polymers on the Release of Naproxen from Sustained Release Tablets. Research J. Pharm. and Tech, 2010; 4:776-780. DOI: 10.5958/0974-360X
19. Bendgude Namdeo, Poddar Sushilkumar. An Overview on Designing of Multilayered Matrix Tablets. Research J. Pharm. and Tech.2 (4): Oct.-Dec. 2009; Page 664-669. Doi: 10.5958/0974-360X .
20. Manish J, Abhay K. Sustained release matrix type drug delivery system: A review. Journal of Drug Delivery and Therapeutics, 2012; 2:142–148.
21. Ghori MU, Conway B. Hydrophilic matrices for oral control drug delivery. Am J Pharmacol Sci,2015; 3:103-109.
22. Basak SC, Jayakumar RB, Lucas Mani K. Formulation and release behaviour of sustained release Ambroxol hydrochloride HPMC matrix tablet. Indian J Pharm Sci, 2006; 68:594- 8.
23. Chandran S, Asghar LF, Mantha N. Design and evaluation of ethyl cellulose based matrix tablets of Ibuprofen with pH modulated release kinetics. Indian J Pharm Sc,i 2008;70: 596-602.
24. Nisargi S, Chintan O, Shital T, Nihar S, Shreeraj S. Review on sustained release matrix tablets: An approach to prolong the release of drug. Journal of Pharmaceutical Science and Bioscintific Research, 2015; 5:315-321
25. Rancan F, Blume-Peytavi U, Vogt A. Utilization of biodegradable polymeric materials as delivery agents in dermatology. Clin CosmetInvestig Dermatol,2014;7:23-34.
26. Varshosaz J, Tavakoli N, Kheirolahi F. Use of hydrophilic natural gums in formulation of sustained-release matrix tablets of tramadol hydrochloride. AAPS PharmSciTech,2006; 7:168-174.
27. Amarjeet D, Ankur R, Seema R, Mu K. Gastroretentive dosage forms: Review on floating drug delivery systems. International Research Journal of Pharmacy, 2011; 2:72-78.
28. Gambhire MN, Ambade KW, Kurmi SD, Kadam VJ, Jadhav KR. Development and in vitro evaluation of an oral floating matrix tablet formulation of diltiazem hydrochloride. AAPS PharmSciTech, 2007; 8:E1-E9.
29. Balamuralidhara V, Pramod kumar TM, Srujana N, Venkatesh MP, Gupta NV, Krishna KL. pH sensitive drug delivery systems: a review. Am J Drug Discovery Dev, 2011; 1:24-48.
30. Arora G, Malik K, Singh I, Arora S, Rana V. Formulation and evaluation of controlled release matrix mucoadhesive tablets of domperidone using salvia plebeian gum. J Adv Pharm Technol Res, 2011; 2:163-9.
31. Andhale VA, Patil PR, Dhas AU, Chauhan PD, Desai S V. Liposome: An emerging tool in drug carrier system. Int J Pharm Technol 2016; 8:10982-11011.
32. Bhargava A, Rathore RPS, Tanwar YS, Gupta S, Bhaduka G. Oral sustained release dosage form: An opportunity to prolong the release of drug. International Journal Advanced Research in Pharmaceutical and Bioscience, 2013; 3:7-14.
33. Garg C, Saluja V. Once-daily sustained-release matrix tablets of metformin HCl based on an enteric polymer and chitosan. Journal of Pharmaceutical Eduction and Research, 2013; 4:92-7.
34. Ashish S, Vikas B. Sustained release matrix type drug delivery system: A review. World Journal of Pharmacy and Pharmaceutical Sciences, 2015; 4:1002-1022.
35. Varma MVS, Kaushal AM, Garg A, Garg S. Factors affecting mechanism and kinetics of drug release from matrix-based oral controlled drug delivery systems. Am J Drug Deliv, 2004; 2:43-57.
36. Patiwala MSM, Jethara S, Patel MR. Recent trends in sustained release oral drug delivery system: A promising approach. World Journal of Pharmaceutical Research 2015; 4:526- 552.
37. Aulton ME. Pharmaceutics. The Science of Dosage Form Design. 2nd edn. Churchill Livingstone, London: Harcourt Publ Limited, 2005; 85:296-8.
38. Neeraj B, Swati S, Sumeena, Tangum, Tanvi B, Simran. Sustained release tablets:- A review. World Journal of Pharmacy and Pharmaceutical Sciences, 2017; 6:290-302.
39. Gupta MM, Ray B. A review on: Sustained release technology. International Journal of Therapeutic Applications, 2012; 8:1-23.
40. Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxy propylmethylcellulose (HPMC). Adv Drug Deliv Rev, 2012; 64:163-174.
41. Chebli C, Cartilier L. Release and swelling kinetics of substituted amylose matrices. J Pharm Belg ,2000; 54:51-4.
42. Phaechamud T, Darunkaisorn W. Drug release behavior of polymeric matrix filled in capsule. Saudi Pharm J, 2016; 24:627-634.
43. Maggi L, Segale L, Torre ML, Ochoa Machiste E, Conte U. Dissolution behaviour of hydrophilic matrix tablets containing two different polyethylene oxides (PEOs) for the controlled release of a water-soluble drug. Dimensionality study. Biomaterials, 2002; 23:1113-9.
44. Grund J, Koerber M, Walther M, Bodmeier, Roland GJ, Koerber M, et al. The effect of polymer properties on direct compression and drug release from water-insoluble controlled release matrix tablets. International Journal of Pharmaceutics, 2014; 469:94-101.
45. PrustyA, Mishra AK and Gupta BK. Development and evaluation of matrix tablet by taking new chemicals combination of Chitosan and Eudragit-l 100. Journal of Young Pharmacists, 2016; 8: 168-176.
46. Misal R, Atish W, Aqueel S. Matrix tablets: A promising technique for controlled drug delivery. Indo American Journal of Pharmaceutical, 2013; 3:791–805.
47. Venkateswarlu K, ShanthI A. Formulation and evaluation of sustained release glipizide matrix. IOSR Journal of Pharmacy and Biological Sciences, 2012; 2:17-23.
48. Kshirsagar S, Upasani A, Bhalekar M. Design and optimization of sustained release matrix tablet of Opipramol HCl by using quality by design approach. Asian J Pharm Clin Res, 2014; 7:227-234.
49. Chien YW. Novel Drug Delivery System. 2nd Edition Revised and Expanded. New York: Informa Health Care, 2009; 55: 1-50.
50. Ray Mridanga Raj,. Design, Development and In Vitro Evaluation of Directly Compressed Sustained Release Matrix Tablet of Famotidine. Research J. Pharm. and Tech,2008;13:175-178.
51. LP Hingmire, Development and Evaluation of Sustained Release Matrix Tablets Using Natural Polymer as Release Modifier. Research J. Pharm. and Tech. 2008; 4:193-196. 51.DOI: 10.5958/0974-360X
52. Khanum Aisha,Comparative Evaluation of Matrix Tablet of Diclofenac Sodium Employing Wet Granulation and Direct Compression Method Using Blend of Polymers. Research J. Pharm. and Tech. 1(3): July-Sept. 2008; Page 265-269. DOI: 10.5958/0974-360X
53. Jain Sourabh,Preparation ;and Evaluation of Sustained Release Matrix Tablet of Furosemide using Natural Polymers. Research J. Pharm. and Tech.2008, 1; 4:374-376. DOI: 10.5958/0974-360X
54. N Jawahar, Design and Evaluation of Sustained Release Hydrophilic Polymer Matrix Tablet of Glucosamine Sulphate. Research J. Pharm. and Tech.2 (3): July-Sept. 2009,; Page 463-465. Doi:10.5958/0974-360X.
55. Manthena V.S. Varma, Factors Affecting Mechanism and Kinetics of Drug Release from Matrix-Based Oral Controlled Drug Delivery Systems. am j drug deliv 2004, 2; 1 :43-57.
56. Sanjay Kumar Kushwaha, Development and Evaluation of Polyherbal Tablet from Some Hepatoprotective Herbs. kushwaha sk et al., sch. acad. j. pharm., 2014, 3; 3:321-326.